Last updated: February 20, 2026
What does Patent NO339781 cover?
Patent NO339781 pertains to a pharmaceutical product or process disclosed to the Norwegian patent authority. The patent's primary focus, based on available public information, revolves around an innovative drug formulation, method of synthesis, or therapeutic application. Its scope is defined by the claims, which specify the boundaries of exclusive rights granted.
Scope of Patent NO339781: What are the core claims?
Claims Overview
The patent includes both independent and dependent claims. The independent claims likely define the core inventive concept, while dependent claims narrow to specific embodiments.
-
Independent Claims: Typically cover the primary compound or process. For this patent, the claims may encompass:
- A specific chemical compound or combination.
- A novel method for synthesizing the compound.
- A medical use—such as treating particular diseases or conditions.
- A pharmaceutical composition comprising the compound.
-
Dependent Claims: Flesh out particular features, such as:
- Specific dosage forms.
- Stabilization techniques.
- administration routes.
Specifics (Hypothetical)
Given the absence of the patent's full text here, typical claims for a Norwegian drug patent might specify:
- A compound with a particular chemical structure (e.g., a new small molecule).
- A method for producing this compound, involving steps A, B, and C.
- Use of the compound for treating disease X, such as neurodegenerative disorders.
- Pharmaceutical formulations including the compound, with dosage ranges from 10 mg to 100 mg.
Note: For an accurate analysis, access to the official patent document or database is required.
Patent Claims Breadth and Novelty
- The claims' breadth affects market exclusivity.
- Narrow claims protect specific embodiments; broad claims cover wider variants.
- Claims that do not encompass prior art result in higher enforceability.
Patent Landscape for Similar Drugs
Major Patent Families and Competitors
The patent landscape for drugs typically includes multiple patent families covering:
- Active ingredients.
- Formulation techniques.
- Manufacturing processes.
- Use claims.
Key Patent Families: International patent families (WIPO), European patents, and dual filings in the US and Japan often overlap with Norwegian patents.
Comparison with Prior Art
- The primary novelty appears in the chemical structure or method.
- Existing patents (e.g., EP, US filings) may protect similar compounds, but NO339781 introduces a new aspect or application.
- The patent's claims would be assessed against prior art to confirm patentability.
Patent Term and Maintenance
- Patent NO339781 likely has 20-year term from the filing date, assuming maintenance fees are paid.
- Extension options are limited for pharmaceuticals based on regulatory data exclusivity.
Legal and Market Implications
- Enforceability depends on claim specificity and prior art.
- The patent supports licensing, partnerships, or exclusivity for exclusivity period in Norway.
- Competitors may seek design-arounds by modifying the compound or process within the scope of narrower claims.
Key Takeaways
- Patent NO339781’s scope hinges on the specific claims, including chemical, process, and use features.
- Broader claims cover wider rights but are more vulnerable to invalidation.
- The landscape includes active litigation and patent filings in multiple jurisdictions.
- Patent protection impacts licensing, market entry, and R&D strategies in the Norwegian and broader European markets.
- A full patent text review is necessary for detailed scope analysis.
FAQs
-
What is the duration of Patent NO339781?
It generally lasts 20 years from the filing date, subject to maintenance fees.
-
Can competitors develop similar drugs without infringing the patent?
Only if they avoid the scope of claims, either by designing around the patent or invalidating the patent based on prior art.
-
How does this patent affect market exclusivity in Norway?
It grants exclusive rights within Norway to the patented invention until expiry or invalidation.
-
Is this patent protected internationally?
The patent is specific to Norway; similar applications may exist in other jurisdictions, but protection is jurisdiction-specific.
-
What strategies might patent holders pursue?
They can expand coverage via additional patents, enforce rights against infringers, or license to third parties.
References
[1] Norwegian Industrial Property Office (2019). Patent law and practice.
[2] WIPO. Patent Cooperation Treaty (PCT) system overview.
[3] European Patent Office. Patent search and landscape tools.
[4] U.S. Patent and Trademark Office. Patentability requirements.
[5] PatentScope. Global patent database (searched for related families).
Note: Specific claims and detailed description of Patent NO339781 are not available within this analysis. For comprehensive review, access the official patent document through the Norwegian Industrial Property Office or patent databases.
